NEW YORK (GenomeWeb) – OpGen reported after the close of the market on Thursday that its fourth quarter revenue was flat year over year.

For the three months ended Dec. 31, the company reported revenues of $990,912, down from $1.0 million in Q4 2016.

Product sales fell 23 percent to $626,498 from $818,488 a year ago. Lab services revenues fell 98 percent to $935 from $46,774, and collaboration revenues rose 157 percent to $363,479 from $141,301 year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.

Jul
19
Sponsored by
Thermo Fisher Scientific

This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research. 

Jul
25
Sponsored by
Streck

This online seminar will discuss the advantages of incorporating molecular testing into the microbiology laboratory to aid in the identification of relevant antibiotic resistance mechanisms.